go back

Indium In-111 Ibritumomab Tiuxetan, Diagnostic

New Mexico rates for HCPCS A9542

Indium In-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 mCi

Rates data updated July 2026.

Facilitymedian $6,761 · 10th–90th $3,020$7,0790%20%10th90th$6,761Professionalmedian $3,020 · 10th–90th $2,754$4,1690%20%10th90th$3,020$100.0$200.0$500.0$1.0K$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$3,019.95
Median
$3,019.95
Typical High
$3,019.95
Aetna
Setting
Professional
Modifier
Global
Typical Low
$2,754.23
Median
$3,019.95
Typical High
$3,019.95
Cigna
Setting
Facility
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$7,079.46
Cigna
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
Molina
Setting
Professional
Modifier
Global
Typical Low
$60.26
Median
$2,951.21
Typical High
$6,309.57
Providence
Setting
Facility
Modifier
Global
Typical Low
$2,344.23
Median
$3,548.13
Typical High
$7,079.46
Providence
Setting
Professional
Modifier
Global
Typical Low
$3,548.13
Median
$3,548.13
Typical High
$3,548.13
United
Setting
Facility
Modifier
Global
Typical Low
$5,011.87
Median
$6,760.83
Typical High
$6,760.83
United
Setting
Professional
Modifier
Global
Typical Low
$4,168.69
Median
$4,168.69
Typical High
$4,168.69